28 May 2021 in Science Immunology
MIS-C is characterized by a polyclonal activation of Vβ21.3+CD4+and CD8+T cells that poorly respond to SARS-CoV-2 antigens.
14 February 2012 in Cellular Microbiology
Staphylococcus aureus is a major pathogen responsible for both nosocomial and community‐acquired infections. Central to its virulence is its ability to secrete haemolysins, pore‐forming toxins and cytolytic peptides. The large number of membrane‐damaging toxins and peptides produced during S. aureus infections has hindered a precise understanding of their specific roles in diseases. Here, we used comprehensive libraries of recombinant toxins and synthetic cytolytic peptides, of S. aureus mutants and clinical strains to investigate the role of these virulence factors in targeting human macrophages and triggering IL‐1β release. We found that the Panton Valentine leukocidin (PVL) is the major trigger of IL‐1β release and inflammasome activation in primary human macrophages. The cytolytic peptides, δ‐haemolysin and PSMα3; the pore‐forming toxins, γ‐haemolysin and LukDE; and β‐haemolysin synergize with PVL to amplify IL‐1β release, indicating that these factors cooperate with PVL to trigger inflammation. PVL+S. aureus causes necrotizing pneumonia in children and young adults. The severity of this disease is due to the massive recruitment of neutrophils that cause lung damage. Importantly, we demonstrate that PVL triggers IL‐1β release in human alveolar macrophages. Furthermore, IL‐1β released by PVL‐intoxicated macrophages stimulates the secretion of the neutrophil attracting chemokines, IL‐8 and monocyte chemotactic protein‐1, by lung epithelial cells. Finally, we show that PVL‐induced IL‐8/monocyte chemotactic protein‐1 release is abolished by the inclusion of IL‐1 receptor antagonist (IL‐1Ra) in a mixed culture of lung epithelial cells and macrophages. Together, our results identify PVL as the predominant S. aureus secreted factor for triggering inflammasome activation in human macrophages and demonstrate how PVL‐intoxicated macrophages orchestrate inflammation in the lung. Finally, our work suggests that anakinra, a synthetic IL‐1Ra, may be an effective therapeutic agent to reduce the massive neutrophils infiltration observed during necrotizing pneumonia and decrease the resulting host‐mediated lung injury.
1 October 2008 in Journal of Clinical Microbiology
We conducted a prospective multicenter study of methicillin-resistant Staphylococcus aureus (MRSA) isolates, including the first five consecutive clinical isolates, collected between September 2006 and February 2007 in 23 hospitals located throughout France (Fig. 1). The 111 isolates were tested for their antibiotic susceptibility patterns and were extensively characterized by screening for drug resistance and agr alleles, multilocus sequence typing (ST), staphylococcal cassette chromosome mec (SCC mec ) typing, spa typing, and PCR profiling of 21 toxin genes. Clones were designated by their ST followed by their SCC mec type (I to VI). The Lyon clone ST8-IV or ST8-IV variant ( n = 77; 69.4%) was widely distributed. Four minor clones were also detected, namely, the “classical” Pediatric clone ST5-IV ( n = 9; 8.1%), the “new” Pediatric clone ST5-VI ( n = 8; 7.2%), the clone Geraldine ST5-I truncated ( n = 7; 6.3%), and the European clone ST80-IV ( n = 4; 3.6%). The six other isolates were related to five rare clones. Relative to that of other European countries, the situation in France is marked by the predominance of a specific major clone and the worrying emergence of minor clones with enhanced virulence and new antibiotic susceptibility profiles.
1 June 2007 in Journal of Hospital Infection